Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
The arrival of oral GLP‑1 therapy for type 2 diabetes marks a pivotal shift in diabetes care. Traditionally available only as injections, GLP‑1 receptor agonists have shown impressive results in lowering blood glucose, aiding in weight loss, and protecting the heart. Now, oral versions like semaglutide are removing barriers for …
Read More »Oral GLP‑1 Therapy for Type 2 Diabetes: Why Pills Could Change the Playbook
